{"transactions":[{"id":758680,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43158,"kind":"person","name":"Adams Helen C.","position":1,"cik":"0001488486","reported_name":"Adams Helen C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T21:05:26.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":8.78,"expiration_date":"2036-05-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-26-026429","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488486/000149315226026429/ownership.xml","form_type":"4"}},{"id":758679,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43158,"kind":"person","name":"Adams Helen C.","position":1,"cik":"0001488486","reported_name":"Adams Helen C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T21:05:26.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 6,250 restricted stock units (\"RSUs\") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the \"2027 Annual Meeting\") is held, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":181004,"source":{"system":"sec-edgar","filing":"0001493152-26-026429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488486/000149315226026429/ownership.xml","form_type":"4"}},{"id":758288,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T21:05:25.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":8.78,"expiration_date":"2036-05-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-26-026430","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226026430/ownership.xml","form_type":"4"}},{"id":758287,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T21:05:25.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 6,250 restricted stock units (\"RSUs\") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the \"2027 Annual Meeting\") is held, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":26250,"source":{"system":"sec-edgar","filing":"0001493152-26-026430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226026430/ownership.xml","form_type":"4"}},{"id":758410,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T21:05:23.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":8.78,"expiration_date":"2036-05-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-26-026427","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000149315226026427/ownership.xml","form_type":"4"}},{"id":758409,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T21:05:23.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 6,250 restricted stock units (\"RSUs\") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the \"2027 Annual Meeting\") is held, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":52342,"source":{"system":"sec-edgar","filing":"0001493152-26-026427","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000149315226026427/ownership.xml","form_type":"4"}},{"id":758927,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T21:05:22.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":500000,"derivative":{"exercise_price":8.78,"expiration_date":"2036-05-22","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-26-026428","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315226026428/ownership.xml","form_type":"4"}},{"id":759073,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":26325,"kind":"person","name":"CHANG NANCY T","position":1,"cik":"0001135041","reported_name":"CHANG NANCY T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T21:05:20.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":8.78,"expiration_date":"2036-05-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-26-026426","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1135041/000149315226026426/ownership.xml","form_type":"4"}},{"id":759072,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":26325,"kind":"person","name":"CHANG NANCY T","position":1,"cik":"0001135041","reported_name":"CHANG NANCY T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T21:05:20.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 6,250 restricted stock units (\"RSUs\") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the \"2027 Annual Meeting\") is held, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":428190,"source":{"system":"sec-edgar","filing":"0001493152-26-026426","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1135041/000149315226026426/ownership.xml","form_type":"4"}},{"id":758286,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T21:05:19.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":500000,"derivative":{"exercise_price":8.78,"expiration_date":"2036-05-22","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-26-026425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226026425/ownership.xml","form_type":"4"}},{"id":758285,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T21:05:17.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":8.78,"expiration_date":"2036-05-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-26-026424","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226026424/ownership.xml","form_type":"4"}},{"id":758284,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T21:05:17.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 6,250 restricted stock units (\"RSUs\") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the \"2027 Annual Meeting\") is held, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001493152-26-026424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226026424/ownership.xml","form_type":"4"}},{"id":758929,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T21:05:15.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":8.78,"expiration_date":"2036-05-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-26-026422","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315226026422/ownership.xml","form_type":"4"}},{"id":758928,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T21:05:15.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 6,250 restricted stock units (\"RSUs\") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the \"2027 Annual Meeting\") is held, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":899250,"source":{"system":"sec-edgar","filing":"0001493152-26-026422","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315226026422/ownership.xml","form_type":"4"}},{"id":758526,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43135,"kind":"person","name":"BUCHAN JANE","position":1,"cik":"0001342502","reported_name":"BUCHAN JANE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T21:05:14.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":8.78,"expiration_date":"2036-05-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-26-026423","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1342502/000149315226026423/ownership.xml","form_type":"4"}},{"id":758525,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43135,"kind":"person","name":"BUCHAN JANE","position":1,"cik":"0001342502","reported_name":"BUCHAN JANE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T21:05:14.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 6,250 restricted stock units (\"RSUs\") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the \"2027 Annual Meeting\") is held, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":28705,"source":{"system":"sec-edgar","filing":"0001493152-26-026423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1342502/000149315226026423/ownership.xml","form_type":"4"}},{"id":972979,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":26325,"kind":"person","name":"CHANG NANCY T","position":1,"cik":"0001135041","reported_name":"CHANG NANCY T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-12T01:00:32.000Z","date":"2025-11-21","kind":"grant","planned":false,"acquired":true,"shares":39643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in thirty-six (36) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer and the terms of a Stock Option Agreement entered into to evidence the award."}],"balance_after":39643,"derivative":{"exercise_price":4.33,"expiration_date":"2035-11-21","underlying":"Common Stock","underlying_shares":39643},"source":{"system":"sec-edgar","filing":"0001493152-25-027329","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1135041/000149315225027329/ownership.xml","form_type":"4"}},{"id":973840,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-12-10T23:49:30.000Z","date":"2025-12-10","kind":"purchase","planned":false,"acquired":true,"shares":746,"price":6.67,"value":4975.82,"ownership":{"direct":true},"balance_after":1141683,"source":{"system":"sec-edgar","filing":"0001493152-25-027109","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315225027109/ownership.xml","form_type":"4"}},{"id":974656,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Warrants (right to purchase)","published_at":"2025-12-10T23:47:20.000Z","date":"2025-12-08","kind":"other","planned":false,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC (\"Alwaysraise\") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The warrants were held by Alwaysraise LLC."}],"balance_after":0,"derivative":{"exercise_price":0.8,"exercise_date":"2021-04-02","expiration_date":"2031-04-02","underlying":"Common stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001493152-25-027107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315225027107/ownership.xml","form_type":"4"}},{"id":974655,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Warrants (right to purchase)","published_at":"2025-12-10T23:47:20.000Z","date":"2025-12-08","kind":"other","planned":false,"acquired":false,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC (\"Alwaysraise\") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The warrants were held by Alwaysraise LLC."}],"balance_after":0,"derivative":{"exercise_price":0.8,"exercise_date":"2021-03-18","expiration_date":"2031-03-18","underlying":"Common stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001493152-25-027107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315225027107/ownership.xml","form_type":"4"}},{"id":974654,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-12-10T23:47:20.000Z","date":"2025-12-10","kind":"purchase","planned":false,"acquired":true,"shares":770,"price":6.58,"value":5066.6,"ownership":{"direct":true},"balance_after":291429,"source":{"system":"sec-edgar","filing":"0001493152-25-027107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315225027107/ownership.xml","form_type":"4"}},{"id":974653,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-12-10T23:47:20.000Z","date":"2025-12-08","kind":"other","planned":false,"acquired":true,"shares":156000,"price":0.8,"value":124800.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC (\"Alwaysraise\") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein."}],"balance_after":426844,"source":{"system":"sec-edgar","filing":"0001493152-25-027107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315225027107/ownership.xml","form_type":"4"}},{"id":1036905,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-09-17T21:20:33.000Z","date":"2025-09-17","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2.02,"value":5050.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price of purchases which transactions occurred at purchase prices from $2.01 to $2.02 per share, inclusive. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1140937,"source":{"system":"sec-edgar","filing":"0001493152-25-013919","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315225013919/ownership.xml","form_type":"4"}},{"id":1038066,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-09-17T21:20:32.000Z","date":"2025-09-16","kind":"purchase","planned":false,"acquired":true,"shares":2600,"price":1.97,"value":5122.0,"ownership":{"direct":true},"balance_after":290659,"source":{"system":"sec-edgar","filing":"0001493152-25-013918","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315225013918/ownership.xml","form_type":"4"}},{"id":1103383,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T20:57:40.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":33000,"derivative":{"exercise_price":2.24,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001641172-25-016115","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000164117225016115/ownership.xml","form_type":"4"}},{"id":1103993,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T20:57:38.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":340000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option will vest in forty-eight (48) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":340000,"derivative":{"exercise_price":2.24,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0001641172-25-016114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000164117225016114/ownership.xml","form_type":"4"}},{"id":1103439,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T20:57:36.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":33000,"derivative":{"exercise_price":2.24,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001641172-25-016113","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000164117225016113/ownership.xml","form_type":"4"}},{"id":1103995,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T20:57:35.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":33000,"derivative":{"exercise_price":2.24,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001641172-25-016112","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000164117225016112/ownership.xml","form_type":"4"}},{"id":1103719,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43158,"kind":"person","name":"Adams Helen C.","position":1,"cik":"0001488486","reported_name":"Adams Helen C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T20:57:33.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":33000,"derivative":{"exercise_price":2.24,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001641172-25-016109","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488486/000164117225016109/ownership.xml","form_type":"4"}},{"id":1103537,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43135,"kind":"person","name":"BUCHAN JANE","position":1,"cik":"0001342502","reported_name":"BUCHAN JANE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T20:57:32.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":33000,"derivative":{"exercise_price":2.24,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001641172-25-016110","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1342502/000164117225016110/ownership.xml","form_type":"4"}},{"id":1103382,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T20:57:30.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":340000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in forty-eight (48) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":340000,"derivative":{"exercise_price":2.24,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0001641172-25-016116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000164117225016116/ownership.xml","form_type":"4"}},{"id":1103381,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T20:57:30.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":33000,"derivative":{"exercise_price":2.24,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001641172-25-016111","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000164117225016111/ownership.xml","form_type":"4"}},{"id":1104511,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-06-20T13:35:32.000Z","date":"2025-06-18","kind":"purchase","planned":false,"acquired":true,"shares":2178,"price":2.295,"value":4998.51,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1138437,"source":{"system":"sec-edgar","filing":"0001641172-25-015756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000164117225015756/ownership.xml","form_type":"4"}},{"id":1105168,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-06-20T13:35:31.000Z","date":"2025-06-18","kind":"purchase","planned":false,"acquired":true,"shares":2225,"price":2.279,"value":5070.775,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Volume-weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":288059,"source":{"system":"sec-edgar","filing":"0001641172-25-015755","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000164117225015755/ownership.xml","form_type":"4"}},{"id":1321881,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-26T21:20:11.000Z","date":"2024-12-23","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":2.192,"value":87680.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.147 to $2.25, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":893000,"source":{"system":"sec-edgar","filing":"0001493152-24-052103","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315224052103/ownership.xml","form_type":"4"}},{"id":1321880,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-26T21:20:11.000Z","date":"2024-12-20","kind":"purchase","planned":false,"acquired":true,"shares":7700,"price":2.166,"value":16678.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.11 to $2.21, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":853000,"source":{"system":"sec-edgar","filing":"0001493152-24-052103","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315224052103/ownership.xml","form_type":"4"}},{"id":1423414,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T20:45:32.000Z","date":"2024-08-22","kind":"purchase","planned":false,"acquired":true,"shares":8100,"price":2.251,"value":18233.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.162 to $2.29, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":845300,"source":{"system":"sec-edgar","filing":"0001493152-24-033900","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315224033900/ownership.xml","form_type":"4"}},{"id":1423413,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T20:45:32.000Z","date":"2024-08-21","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":2.226,"value":33390.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.22 to $2.23, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":837200,"source":{"system":"sec-edgar","filing":"0001493152-24-033900","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315224033900/ownership.xml","form_type":"4"}},{"id":1428628,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-20T00:45:04.000Z","date":"2024-08-16","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.86,"value":18600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.84 to $1.915, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001493152-24-033205","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224033205/ownership.xml","form_type":"4"}},{"id":1445438,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T01:15:28.000Z","date":"2024-07-24","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":2.1462,"value":12877.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.1191 to $2.166, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":822200,"source":{"system":"sec-edgar","filing":"0001493152-24-029810","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315224029810/ownership.xml","form_type":"4"}},{"id":1445437,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T01:15:28.000Z","date":"2024-07-18","kind":"purchase","planned":false,"acquired":true,"shares":3200,"price":2.0748,"value":6639.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.06 to $2.07576, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":816200,"source":{"system":"sec-edgar","filing":"0001493152-24-029810","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315224029810/ownership.xml","form_type":"4"}},{"id":1471692,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:45:17.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":33000,"derivative":{"exercise_price":2.04,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001493152-24-024825","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000149315224024825/ownership.xml","form_type":"4"}},{"id":1471596,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:45:16.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":33000,"derivative":{"exercise_price":2.04,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001493152-24-024823","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224024823/ownership.xml","form_type":"4"}},{"id":1472263,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:45:14.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":33000,"derivative":{"exercise_price":2.04,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001493152-24-024824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315224024824/ownership.xml","form_type":"4"}},{"id":1471595,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:45:13.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":340000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":340000,"derivative":{"exercise_price":2.04,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0001493152-24-024828","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224024828/ownership.xml","form_type":"4"}},{"id":1471812,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43135,"kind":"person","name":"BUCHAN JANE","position":1,"cik":"0001342502","reported_name":"BUCHAN JANE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:45:11.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":33000,"derivative":{"exercise_price":2.04,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001493152-24-024822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1342502/000149315224024822/ownership.xml","form_type":"4"}},{"id":1471594,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:45:11.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":33000,"derivative":{"exercise_price":2.04,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001493152-24-024827","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224024827/ownership.xml","form_type":"4"}},{"id":1472261,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:45:10.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":340000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":340000,"derivative":{"exercise_price":2.04,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0001493152-24-024826","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224024826/ownership.xml","form_type":"4"}},{"id":1471996,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43158,"kind":"person","name":"Adams Helen C.","position":1,"cik":"0001488486","reported_name":"Adams Helen C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:45:10.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":33000,"derivative":{"exercise_price":2.04,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001493152-24-024821","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488486/000149315224024821/ownership.xml","form_type":"4"}},{"id":1485211,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-06-10T13:00:16.000Z","date":"2024-06-07","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2.1192,"value":5298.0,"ownership":{"direct":true},"balance_after":285834,"source":{"system":"sec-edgar","filing":"0001493152-24-023288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224023288/ownership.xml","form_type":"4"}},{"id":1484349,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2024-06-10T13:00:16.000Z","date":"2024-06-07","kind":"purchase","planned":false,"acquired":true,"shares":2600,"price":2.13,"value":5538.0,"ownership":{"direct":true},"balance_after":1136259,"source":{"system":"sec-edgar","filing":"0001493152-24-023287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224023287/ownership.xml","form_type":"4"}},{"id":1490345,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-06-05T13:00:26.000Z","date":"2024-06-04","kind":"purchase","planned":false,"acquired":true,"shares":3300,"price":1.8099,"value":5972.67,"ownership":{"direct":true},"balance_after":283334,"source":{"system":"sec-edgar","filing":"0001493152-24-022654","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224022654/ownership.xml","form_type":"4"}},{"id":1489288,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2024-06-05T13:00:12.000Z","date":"2024-06-04","kind":"purchase","planned":false,"acquired":true,"shares":3300,"price":1.8091,"value":5970.03,"ownership":{"direct":true},"balance_after":1133659,"source":{"system":"sec-edgar","filing":"0001493152-24-022653","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224022653/ownership.xml","form_type":"4"}},{"id":1508935,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43158,"kind":"person","name":"Adams Helen C.","position":1,"cik":"0001488486","reported_name":"Adams Helen C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-20T21:25:55.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":74241,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity."}],"balance_after":174754,"source":{"system":"sec-edgar","filing":"0001493152-24-020777","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488486/000149315224020777/ownership.xml","form_type":"4"}},{"id":1508934,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43158,"kind":"person","name":"Adams Helen C.","position":1,"cik":"0001488486","reported_name":"Adams Helen C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-20T21:25:55.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":87740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted Stock Awards which will vest in thirteen (13) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":100740,"source":{"system":"sec-edgar","filing":"0001493152-24-020777","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488486/000149315224020777/ownership.xml","form_type":"4"}},{"id":1508348,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2024-05-20T21:25:52.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":218359,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity."}],"balance_after":1130359,"source":{"system":"sec-edgar","filing":"0001493152-24-020778","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224020778/ownership.xml","form_type":"4"}},{"id":1509212,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-20T21:25:48.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":25512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option will vest in thirteen (13) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":25512,"derivative":{"exercise_price":2.47,"expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":25512},"source":{"system":"sec-edgar","filing":"0001493152-24-020780","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315224020780/ownership.xml","form_type":"4"}},{"id":1509211,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-20T21:25:48.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":21587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024."}],"balance_after":21587,"derivative":{"exercise_price":2.47,"exercise_date":"2024-05-15","expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":21587},"source":{"system":"sec-edgar","filing":"0001493152-24-020780","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315224020780/ownership.xml","form_type":"4"}},{"id":1508685,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43135,"kind":"person","name":"BUCHAN JANE","position":1,"cik":"0001342502","reported_name":"BUCHAN JANE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-20T21:25:45.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":24153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option will vest in thirteen (13) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":24153,"derivative":{"exercise_price":2.47,"expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":24153},"source":{"system":"sec-edgar","filing":"0001493152-24-020779","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1342502/000149315224020779/ownership.xml","form_type":"4"}},{"id":1508684,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43135,"kind":"person","name":"BUCHAN JANE","position":1,"cik":"0001342502","reported_name":"BUCHAN JANE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-20T21:25:45.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":20436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024."}],"balance_after":20436,"derivative":{"exercise_price":2.47,"exercise_date":"2024-05-15","expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":20436},"source":{"system":"sec-edgar","filing":"0001493152-24-020779","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1342502/000149315224020779/ownership.xml","form_type":"4"}},{"id":1508683,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43135,"kind":"person","name":"BUCHAN JANE","position":1,"cik":"0001342502","reported_name":"BUCHAN JANE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-20T21:25:45.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":1127,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity."}],"balance_after":22455,"source":{"system":"sec-edgar","filing":"0001493152-24-020779","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1342502/000149315224020779/ownership.xml","form_type":"4"}},{"id":1508682,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43135,"kind":"person","name":"BUCHAN JANE","position":1,"cik":"0001342502","reported_name":"BUCHAN JANE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-20T21:25:45.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":1332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted Stock Awards which will vest in thirteen (13) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":21332,"source":{"system":"sec-edgar","filing":"0001493152-24-020779","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1342502/000149315224020779/ownership.xml","form_type":"4"}},{"id":1508490,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-20T21:25:42.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":21155,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity."}],"balance_after":46092,"source":{"system":"sec-edgar","filing":"0001493152-24-020781","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000149315224020781/ownership.xml","form_type":"4"}},{"id":1508489,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-20T21:25:42.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":25002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted Stock Awards which will vest in thirteen (13) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":25002,"source":{"system":"sec-edgar","filing":"0001493152-24-020781","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000149315224020781/ownership.xml","form_type":"4"}},{"id":1508347,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-20T21:25:38.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":25512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option will vest in thirteen (13) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":25512,"derivative":{"exercise_price":2.47,"expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":25512},"source":{"system":"sec-edgar","filing":"0001493152-24-020775","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224020775/ownership.xml","form_type":"4"}},{"id":1508346,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-20T21:25:38.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":21587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024."}],"balance_after":21587,"derivative":{"exercise_price":2.47,"exercise_date":"2024-05-15","expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":21587},"source":{"system":"sec-edgar","filing":"0001493152-24-020775","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224020775/ownership.xml","form_type":"4"}},{"id":1509200,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-05-20T21:25:35.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":24141,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC (\"Alwaysraise Ventures\"), the general partner of Alwaysraise Ventures I, LP. (\"AVILP\") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein."}],"balance_after":24141,"source":{"system":"sec-edgar","filing":"0001493152-24-020776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224020776/ownership.xml","form_type":"4"}},{"id":1509199,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-05-20T21:25:35.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":24141,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC (\"Alwaysraise\") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein."}],"balance_after":270844,"source":{"system":"sec-edgar","filing":"0001493152-24-020776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224020776/ownership.xml","form_type":"4"}},{"id":1509198,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-05-20T21:25:35.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":194218,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity."}],"balance_after":280034,"source":{"system":"sec-edgar","filing":"0001493152-24-020776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224020776/ownership.xml","form_type":"4"}},{"id":1517744,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-05-15T01:29:40.000Z","date":"2024-05-14","kind":"purchase","planned":false,"acquired":true,"shares":4500,"price":2.2315,"value":10041.75,"ownership":{"direct":true},"balance_after":85816,"source":{"system":"sec-edgar","filing":"0001493152-24-019368","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315224019368/ownership.xml","form_type":"4"}},{"id":1516907,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2024-05-15T01:28:17.000Z","date":"2024-05-14","kind":"purchase","planned":false,"acquired":true,"shares":4300,"price":2.2465,"value":9659.95,"ownership":{"direct":true},"balance_after":912000,"source":{"system":"sec-edgar","filing":"0001493152-24-019366","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224019366/ownership.xml","form_type":"4"}},{"id":1714609,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-12T23:25:25.000Z","date":"2023-12-11","kind":"purchase","planned":false,"acquired":true,"shares":31000,"price":4.674,"value":144894.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $4.646 to $4.733, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":813000,"source":{"system":"sec-edgar","filing":"0001493152-23-044618","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315223044618/ownership.xml","form_type":"4"}},{"id":1714608,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-12T23:25:25.000Z","date":"2023-12-08","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":4.881,"value":122025.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $4.796 to $4.978, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":782000,"source":{"system":"sec-edgar","filing":"0001493152-23-044618","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315223044618/ownership.xml","form_type":"4"}},{"id":1745889,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options","published_at":"2023-11-10T00:57:06.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":293000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over 48 months from the date of grant."}],"balance_after":293000,"derivative":{"exercise_price":1.86,"expiration_date":"2033-08-14","underlying":"Common Stock","underlying_shares":293000},"source":{"system":"sec-edgar","filing":"0001493152-23-040177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315223040177/ownership.xml","form_type":"4/A","original_submission_date":"2023-08-14"}},{"id":1745468,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Options","published_at":"2023-11-10T00:54:21.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":293000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over 48 months from the date of grant."}],"balance_after":293000,"derivative":{"exercise_price":1.86,"expiration_date":"2033-08-14","underlying":"Common Stock","underlying_shares":293000},"source":{"system":"sec-edgar","filing":"0001493152-23-040172","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223040172/ownership.xml","form_type":"4/A","original_submission_date":"2023-08-14"}},{"id":1779149,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T23:03:32.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":2.4852,"value":17396.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $2.59 to $2.42, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":757000,"source":{"system":"sec-edgar","filing":"0001493152-23-032969","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315223032969/ownership.xml","form_type":"4"}},{"id":1779148,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T23:03:32.000Z","date":"2023-09-14","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.5772,"value":25772.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $2.598 to $2.56, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":750000,"source":{"system":"sec-edgar","filing":"0001493152-23-032969","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315223032969/ownership.xml","form_type":"4"}},{"id":1779147,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T23:03:32.000Z","date":"2023-09-12","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":2.8288,"value":84864.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.91 to $2.70, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":740000,"source":{"system":"sec-edgar","filing":"0001493152-23-032969","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315223032969/ownership.xml","form_type":"4"}},{"id":1779146,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T23:03:32.000Z","date":"2023-09-11","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.8912,"value":72280.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.9299 to $2.83, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":710000,"source":{"system":"sec-edgar","filing":"0001493152-23-032969","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315223032969/ownership.xml","form_type":"4"}},{"id":1779698,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-15T22:27:44.000Z","date":"2023-09-14","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.576,"value":25760.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.51 to $2.60, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-23-032829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223032829/ownership.xml","form_type":"4"}},{"id":1781010,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43158,"kind":"person","name":"Adams Helen C.","position":1,"cik":"0001488486","reported_name":"Adams Helen C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-14T21:20:59.000Z","date":"2023-09-12","kind":"purchase","planned":false,"acquired":true,"shares":13000,"price":2.9609,"value":38491.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This figure is the weighted average sales price of multiple trades ranging from $2.90 to $3.25 per share. The Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, Immix Biopharma, Inc. or any security holder of Immix Biopharma, Inc. full information about the number of shares sold at each separate price upon request."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001493152-23-032664","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488486/000149315223032664/ownership.xml","form_type":"4"}},{"id":1783133,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-12T20:58:37.000Z","date":"2023-09-08","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.5317,"value":25317.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This figure is the weighted average sales price of multiple trades ranging from $2.51 to $2.559 per share. The Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, Immix Biopharma, Inc. or any security holder of Immix Biopharma, Inc. full information about the number of shares sold at each separate price upon request."}],"balance_after":685000,"source":{"system":"sec-edgar","filing":"0001493152-23-032372","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315223032372/ownership.xml","form_type":"4"}},{"id":1783748,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43135,"kind":"person","name":"BUCHAN JANE","position":1,"cik":"0001342502","reported_name":"BUCHAN MELISSA JANE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-11T21:18:05.000Z","date":"2023-09-07","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.4613,"value":49226.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This figure is the weighted average sales price of multiple trades ranging from $2.39 to $2.49 per share. The Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, Immix Biopharma, Inc. or any security holder of Immix Biopharma, Inc. full information about the number of shares sold at each separate price upon request."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001493152-23-032280","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1342502/000149315223032280/ownership.xml","form_type":"4"}},{"id":1784459,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-08T21:46:34.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":9000,"price":2.4681,"value":22212.9,"ownership":{"direct":false,"nature":"Via ALMA Life Sciences, LLC"},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001493152-23-032150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000149315223032150/ownership.xml","form_type":"4"}},{"id":1786654,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-06T20:33:08.000Z","date":"2023-09-05","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.4722,"value":24722.0,"ownership":{"direct":false,"nature":"Via ALMA Life Sciences, LLC"},"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001493152-23-031838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000149315223031838/ownership.xml","form_type":"4"}},{"id":1788735,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-05T22:43:17.000Z","date":"2023-08-31","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.01,"value":2010.0,"ownership":{"direct":false,"nature":"Via ALMA Life Sciences, LLC"},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001493152-23-031708","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000149315223031708/ownership.xml","form_type":"4"}},{"id":1798295,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-23T20:28:40.000Z","date":"2023-08-22","kind":"grant","planned":false,"acquired":true,"shares":16670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in ten (10) equal monthly installments following the date of grant and any remaining unvested shares will become fully vested and exercisable on the date of the 2024 annual shareholder meeting, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":16670,"derivative":{"exercise_price":1.8,"expiration_date":"2033-08-22","underlying":"Common Stock","underlying_shares":16670},"source":{"system":"sec-edgar","filing":"0001209191-23-047062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000120919123047062/doc4.xml","form_type":"4"}},{"id":1798294,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-23T20:28:40.000Z","date":"2023-08-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in thirty-six (36) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":20000,"derivative":{"exercise_price":1.8,"expiration_date":"2033-08-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-047062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000120919123047062/doc4.xml","form_type":"4"}},{"id":1808339,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43135,"kind":"person","name":"BUCHAN JANE","position":1,"cik":"0001342502","reported_name":"BUCHAN MELISSA JANE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-08-14T20:15:46.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":1.86,"expiration_date":"2033-08-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-23-028475","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1342502/000149315223028475/ownership.xml","form_type":"4"}},{"id":1808775,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options","published_at":"2023-08-14T20:15:45.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":193000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over 48 months from the date of grant."}],"balance_after":193000,"derivative":{"exercise_price":1.86,"expiration_date":"2033-08-11","underlying":"Common Stock","underlying_shares":193000},"source":{"system":"sec-edgar","filing":"0001493152-23-028477","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315223028477/ownership.xml","form_type":"4"}},{"id":1808095,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Options","published_at":"2023-08-14T20:15:42.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":193000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over 48 months from the date of grant."}],"balance_after":193000,"derivative":{"exercise_price":1.86,"expiration_date":"2033-08-11","underlying":"Common Stock","underlying_shares":193000},"source":{"system":"sec-edgar","filing":"0001493152-23-028470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223028470/ownership.xml","form_type":"4"}},{"id":1808094,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43080,"kind":"person","name":"Ng Carey","position":1,"cik":"0001889522","reported_name":"Ng Carey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-08-14T20:15:38.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":1.86,"expiration_date":"2033-08-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-23-028472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223028472/ownership.xml","form_type":"4"}},{"id":1808507,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43158,"kind":"person","name":"Adams Helen C.","position":1,"cik":"0001488486","reported_name":"Adams Helen C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-08-14T20:15:35.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":1.86,"expiration_date":"2033-08-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-23-028471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488486/000149315223028471/ownership.xml","form_type":"4"}},{"id":1808780,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43211,"kind":"person","name":"Hsu Jason","position":1,"cik":"0001895035","reported_name":"Hsu Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-08-14T20:15:31.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":1.86,"expiration_date":"2033-08-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-23-028474","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895035/000149315223028474/ownership.xml","form_type":"4"}},{"id":1808171,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":37128,"kind":"person","name":"Marquet Magda","position":1,"cik":"0001631486","reported_name":"Marquet Magda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-08-14T20:15:28.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":1.86,"expiration_date":"2033-08-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-23-028469","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631486/000149315223028469/ownership.xml","form_type":"4"}},{"id":2115693,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-11-15T22:33:14.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":150,"price":0.99,"value":148.5,"ownership":{"direct":true},"balance_after":907700,"source":{"system":"sec-edgar","filing":"0001493152-22-032557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315222032557/ownership.xml","form_type":"4"}},{"id":2115692,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-11-15T22:33:14.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":1000,"price":0.95,"value":950.0,"ownership":{"direct":true},"balance_after":907550,"source":{"system":"sec-edgar","filing":"0001493152-22-032557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315222032557/ownership.xml","form_type":"4"}},{"id":2115691,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43079,"kind":"person","name":"Rachman Ilya M","position":1,"cik":"0001889334","reported_name":"Rachman Ilya M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-11-15T22:33:14.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":4050,"price":1.019,"value":4126.95,"ownership":{"direct":true},"balance_after":906550,"source":{"system":"sec-edgar","filing":"0001493152-22-032557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315222032557/ownership.xml","form_type":"4"}},{"id":2116457,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":43210,"kind":"person","name":"Morris Gabriel S","position":1,"cik":"0001889967","reported_name":"Morris Gabriel S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-11-15T22:31:08.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":5200,"price":0.94,"value":4888.0,"ownership":{"direct":true},"balance_after":81316,"source":{"system":"sec-edgar","filing":"0001493152-22-032555","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889967/000149315222032555/ownership.xml","form_type":"4"}},{"id":2203059,"issuer":{"id":4958,"kind":"organization","name":"Immix Biopharma, Inc."},"owners":[{"id":125182,"kind":"person","name":"Senn Sean","position":1,"cik":"0001904837","reported_name":"Senn Sean","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Under 10% owner"}}],"security":"Common Stock","published_at":"2022-07-22T20:12:46.000Z","date":"2022-07-14","kind":"sale","acquired":false,"shares":200,"price":2.75,"value":550.0,"ownership":{"direct":true},"balance_after":899800,"source":{"system":"sec-edgar","filing":"0001493152-22-020155","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315222020155/ownership.xml","form_type":"4/A","original_submission_date":"2022-07-18"}}],"next_cursor":"2022-07-22T20:12:46.000000Z,2203059"}